Your search returned 6 results.

Results
	1.	Blood-brain barrier transport pathways for cytoprotective thiols. [electronic resource] by Peterson, Darryl R Sukowski, Ernest J Zikos, Demetrios Producer: 20141229 In: American journal of therapeutics vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	In Vitro Studies on Degradation of Gamma-L-Glutamyl-L-Cysteine and Gamma-L-Glutamyl-D-Cysteine in Blood: Implications for Treatment of Stroke. [electronic resource] by Ikpa, Nsisong Forman, Rachel Garchow, Kendra Sukowski, Ernest Peterson, Darryl R Producer: 20160405 In: American journal of therapeutics vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Treatment with the matricellular protein CCN3 blocks and/or reverses fibrosis development in obesity with diabetic nephropathy. [electronic resource] by Riser, Bruce L Najmabadi, Feridoon Garchow, Kendra Barnes, Jeffrey L Peterson, Darryl R Sukowski, Ernest J Producer: 20150721 In: The American journal of pathology vol. 184 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	A Glutathione Precursor Reduces Oxidative Injury to Cultured Embryonic Cardiomyocytes. [electronic resource] by Peterson, Darryl R Huang, Huiya Peresada, Dmitriy Sukowski, Ernest J White, Carl Stefanov, Gospodin Schweig, Lorene Vazzalwar, Ramesh Producer: 20210618 In: American journal of therapeutics vol. 27 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	CCN3/CCN2 regulation and the fibrosis of diabetic renal disease. [electronic resource] by Riser, Bruce L Najmabadi, Feridoon Perbal, Bernard Rambow, Jo Ann Riser, Melisa L Sukowski, Ernest Yeger, Herman Riser, Sarah C Peterson, Darryl R Producer: 20110714 In: Journal of cell communication and signaling vol. 4 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease. [electronic resource] by Riser, Bruce L Najmabadi, Feridoon Perbal, Bernard Peterson, Darryl R Rambow, Jo Ann Riser, Melisa L Sukowski, Ernest Yeger, Herman Riser, Sarah C Producer: 20090519 In: The American journal of pathology vol. 174 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)